← Back to Search

Exercise Intervention (home walking program and resistance training) for Breast Cancer

N/A
Waitlist Available
Led By Ellis Levine
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 12 weeks
Awards & highlights

Study Summary

This trial looks at whether exercise can help improve the health and quality of life of breast cancer survivors.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of randomized patients who are still on study at the end of the 12 week intervention
Secondary outcome measures
Adherence rate in each of the active intervention arms
Other outcome measures
Body composition
Cardiovascular fitness
Cognitive function
+3 more

Trial Design

5Treatment groups
Experimental Treatment
Active Control
Group I: Arm III (HIIT, resistance training)Experimental Treatment5 Interventions
Participants wear Fitbit and attend supervised HIIT exercise sessions 3 days per week over 12 weeks. Participants receive resistance training as in Arm I.
Group II: Arm II (home-based Zumba program, resistance training)Experimental Treatment6 Interventions
Participants wear Fitbit and receive a XBOX system and the video game to strive for at least 3 50-minute medium or high intensity classes per week over 12 weeks. Participants may also take 20-minute classes or a mixture of 50- and 20-minute classes to meet the target. Participants receive resistance training as in Arm I.
Group III: Arm I (home-based walking program, resistance training)Experimental Treatment7 Interventions
Participants wear Fitbit, receive home-based DVD containing instructions to warm-up and cool-down, and brisk walk 30 minutes per day 5 days a week in order to achieve the 150 minutes per week of moderate intensity exercise. Participants also receive resistance training by watching the illustration video and completing 6 total blocks of 2-week per block exercise using the Thera-BandR exercise bands.
Group IV: Arm V (usual physical activity)Active Control1 Intervention
Participants wear Fitbit and continue their usual physical activity over 12 weeks.
Group V: Arm IV (supervised moderate intensity walking program)Active Control1 Intervention
Participants wear Fitbit and attend supervised moderate intensity walking sessions weekly for 50-60 each over 12 weeks. Participants undergo resistance training as in Arm I.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise Intervention (home walking program and resistance training)
2017
N/A
~90
Exercise Intervention (HIIT program and resistance training)
2017
N/A
~90
Exercise Intervention (home-based Zumba program and resistance training)
2017
N/A
~90
Monitoring Device
2018
Completed Phase 2
~2380

Find a Location

Who is running the clinical trial?

Roswell Park Cancer InstituteLead Sponsor
402 Previous Clinical Trials
30,775 Total Patients Enrolled
10 Trials studying Breast Cancer
1,638 Patients Enrolled for Breast Cancer
Ellis LevinePrincipal InvestigatorRoswell Park Cancer Institute
Tracey L O'ConnorPrincipal InvestigatorRoswell Park Cancer Institute
1 Previous Clinical Trials
130 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being included in this experiment?

"Affirmative. According to clinicaltrials.gov, the trial initially posted on October 6th 2017 is currently recruiting participants. 190 individuals will be recruited from a single centre for this study which was last updated on July 28th 2022."

Answered by AI

Are there any vacancies for participation in this experiment?

"This clinical trial is actively recruiting, as evidenced by its update on July 28th 2022. Initially posted on October 6 2017, the research team are currently searching for suitable participants."

Answered by AI
~11 spots leftby Apr 2025